Table 2.
PANSS and subscale scores for the intervention type across three time periods
| |
|
Risperidone + Raloxifene (n = 25) |
Risperidone + Placebo (n = 25) |
|---|---|---|---|
| Time period | Mean ± SD | Mean ± SD | |
| PANSS score |
Week 0 |
105.52 ± 16.96 |
105.00 ± 11.68 |
| Week 2 |
89.08 ± 16.14 |
94.16 ± 19.78 |
|
| Week 8 |
68.32 ± 21.04 |
82.00 ± 26.14 |
|
| Positive subscale |
Week 0 |
25.76 ± 8.00 |
26.68 ± 7.04 |
| Week 2 |
20.92 ± 5.41 |
24.28 ± 6.33 |
|
| Week 8 |
14.32 ± 4.33 |
21.12 ± 7.07 |
|
| Negative subscale |
Week 0 |
28.04 ± 8.64 |
30.76 ± 9.09 |
| Week 2 |
24.88 ± 8.76 |
28.12 ± 10.88 |
|
| Week 8 |
19.60 ± 8.66 |
23.08 ± 12.08 |
|
| General Psychopathology subscale |
Week 0 |
50.44 ± 9.92 |
47.52 ± 6.46 |
| Week 2 |
43.56 ± 9.30 |
41.88 ± 9.76 |
|
| Week 8 | 34.56 ± 10.78 | 37.84 ± 11.89 |